Ardian reinvests in Neopharmed alongside NB Renaissance


Ardian has reinvested in Italian pharmaceutical company Neopharmed in a deal that sees it hold a joint majority stake with NB Renaissance.



Source link

Leave a Reply

Your email address will not be published.